6 results on '"Viinikainen K"'
Search Results
2. Without ENMG, detecting pediatric vincristine neuropathy is a challenge.
- Author
-
Viinikainen K, Isohanni P, Kanerva J, Lönnqvist T, and Lauronen L
- Abstract
Objective: Vincristine, a widely used anticancer chemotherapy drug, may cause polyneuropathy (PNP), potentially resulting in permanent functional impairment. We characterized the occurrence and development of vincristine-induced neuropathy (VIPN) in early treatment of childhood leukemia., Methods: This prospective study of 35 pediatric acute lymphoblastic leukemia (ALL) patients comprised systematic clinical and electrophysiological studies at both the time of diagnosis and at least one time point during the first months of treatment., Results: After vincristine treatment, all patients had axonal sensorimotor PNP on electroneuromyography (ENMG) In 34/35 patients, the motor and in 24/35 the sensory responses were decreased. Interestingly, in 3 patients PNP was most prominent in the upper limb. However, some children had no PNP symptoms despite moderate ENMG findings, and not all clinical symptoms were correlated with abnormal ENMG., Conclusions: Pediatric VIPN is a sensorimotor, predominantly motor axonal neuropathy. VIPN can be detected even in its early phase by ENMG, but it is difficult to detect by symptoms and clinical examination only ., Significance: Pediatric ALL patients treated with vincristine are at risk of developing VIPN. Since the clinical signs of PNP in acutely ill children are difficult to identify, VIPN can easily be overlooked if ENMG is not performed., Competing Interests: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (© 2024 International Federation of Clinical Neurophysiology. Published by Elsevier B.V.)
- Published
- 2024
- Full Text
- View/download PDF
3. The effects of valproate exposure in utero on behavior and the need for educational support in school-aged children.
- Author
-
Viinikainen K, Eriksson K, Mönkkönen A, Aikiä M, Nieminen P, Heinonen S, and Kälviäinen R
- Subjects
- Carbamazepine adverse effects, Child, Epilepsy drug therapy, Female, Humans, Pregnancy, Pregnancy Complications drug therapy, Schools, Anticonvulsants adverse effects, Cognition drug effects, Education, Special, Mental Disorders chemically induced, Prenatal Exposure Delayed Effects, Valproic Acid adverse effects
- Abstract
Children exposed to valproate monotherapy in utero were evaluated with respect to neurological functioning, behavior, and additional educational needs, and the results were compared with those for age- and gender-matched controls exposed to carbamazepine and children with no prenatal exposure to antiepileptic drugs. We identified from the community-based pregnancy registry of Kuopio University Hospital area (1989-2000) all first-born and school-aged children exposed to valproate (N=13). Neurological and neuropsychological assessments were made clinically, and behavioral problems were assessed with the Conners' Teacher Rating Scale (CTRS). Eight children (62%) exposed to valproate and two (15%) each in the carbamazepine-exposed and nonexposed groups (P=0.022) required educational support. Minor dysmorphic features were noted in eight children (62%) exposed to valproate and in three children (23%) each in the carbamazepine-exposed and nonexposed groups. On CTRS, children exposed to valproate received higher scores, indicating behavioral problems. In our small but population-based study, all children exposed to valproate had minor, and some of them major, cognitive or neurological problems. This difference is clearly observed when assessing each child individually, but the many confounding factors explaining at least part of this difference are difficult to control and avoid in clinical practice. Larger studies with a prospective design are needed to confirm these findings.
- Published
- 2006
- Full Text
- View/download PDF
4. Community-based, prospective, controlled study of obstetric and neonatal outcome of 179 pregnancies in women with epilepsy.
- Author
-
Viinikainen K, Heinonen S, Eriksson K, and Kälviäinen R
- Subjects
- Abnormalities, Drug-Induced diagnosis, Abnormalities, Drug-Induced epidemiology, Adult, Anticonvulsants adverse effects, Anticonvulsants therapeutic use, Apgar Score, Cohort Studies, Congenital Abnormalities diagnosis, Congenital Abnormalities epidemiology, Epilepsy drug therapy, Epilepsy epidemiology, Female, Follow-Up Studies, Humans, Infant, Infant Mortality, Infant, Low Birth Weight, Infant, Newborn, Infant, Small for Gestational Age, Intensive Care, Neonatal, Obstetric Labor Complications diagnosis, Obstetric Labor Complications epidemiology, Outcome Assessment, Health Care, Pregnancy, Pregnancy Complications epidemiology, Prospective Studies, Epilepsy diagnosis, Pregnancy Complications diagnosis, Pregnancy Outcome epidemiology
- Abstract
Purpose: This study evaluated obstetric and neonatal outcome in a community-based cohort of women with active epilepsy (WWAE) compared with the general pregnant population receiving modern obstetric care., Methods: We reviewed the total population who gave birth between January 1989 and October 2000 at Kuopio University Hospital. Obstetric, demographic, and epilepsy data were collected prospectively from 179 singleton pregnancies of women with epilepsy and from 24,778 singleton pregnancies of unaffected controls. The obstetric data from the pregnancy register was supplemented with detailed neurologic data retrieved from the medical records. The data retrieved were comprehensive because of a follow-up strategy according to a predecided protocol., Results: During pregnancy, the seizure frequency was unchanged, or the change was for the better in the majority (83%) of the patients. We found no significant differences between WWAE and controls in the incidence of preeclampsia, preterm labor, or in the rates of caesarean sections, perinatal mortality, or low birth weight. However, the rate of small-for-gestational-age infants was significantly higher, and the head circumference was significantly smaller in WWAE. Apgar score at 1 min was lower in children of WWAE, and the need for care in the neonatal ward and neonatal intensive care were increased as compared with controls. The frequency of major malformations was 4.8% (-0.6-10.2%; 95% confidence interval) in the 127 children of WWAE., Conclusions: Pregnancy course is uncomplicated and neonatal outcome is good in the majority of cases when a predecided protocol is used for the follow-up of WWAE in antenatal and neurologic care. Long-term follow-up of the neurologic and cognitive development of the children of WWAE is still needed.
- Published
- 2006
- Full Text
- View/download PDF
5. Children exposed to valproate in utero--population based evaluation of risks and confounding factors for long-term neurocognitive development.
- Author
-
Eriksson K, Viinikainen K, Mönkkönen A, Aikiä M, Nieminen P, Heinonen S, and Kälviäinen R
- Subjects
- Adolescent, Adult, Child, Cognition Disorders chemically induced, Confounding Factors, Epidemiologic, Developmental Disabilities chemically induced, Female, Humans, Intelligence Tests statistics & numerical data, Male, Mother-Child Relations, Neuropsychological Tests statistics & numerical data, Population, Pregnancy, Prospective Studies, Retrospective Studies, Uterus drug effects, Anticonvulsants toxicity, Cognition Disorders epidemiology, Developmental Disabilities epidemiology, Prenatal Exposure Delayed Effects, Risk, Valproic Acid toxicity
- Abstract
Purpose: To evaluate neurological and cognitive functioning of school-aged (> or =6 years) children exposed to valproate monotherapy in utero in a population based, evaluator-blinded, controlled study., Methods: Studied children (N=39, aged 6.6-13.4 years) and their mothers were identified through a population based pregnancy registry. Mothers with carbamazepine monotherapy and mothers with epilepsy but without antiepileptic drug (AED) treatment during pregnancy and their age and gender matched children served as controls. Hospital records were reviewed and neurological examination (Touwens test), intelligent quotients (IQ) of mothers (WAIS), and children (WISC-III) and neuropsychological assessment of children (NEPSY) were performed evaluator-blinded., Results: The prevalence of low intelligence (FIQ<80) was 19% (4/21) and the prevalence of exceptionally low intelligence (FIQ<70) 10% (2/21) in valproate (VPA) monotherapy exposed children. Children exposed to carbamazepine (CBZ) and children of women with epilepsy but without AED exposure during pregnancy had all at least low average intelligence. The mothers using valproate scored significantly lower (p<0.05) in FIQ, VIQ and PIQ tests and had also significantly lower (p=0.035) educational level. Altogether 21% (8/39) of the children had minor neurological dysfunctions., Conclusions: In a population based setting inheritance and cumulating environmental factors may partly explain the increased prevalence of neurocognitive symptoms in children exposed to valproate in utero although concern about the possible long-term effects of intrauterine valproate exposure does exist.
- Published
- 2005
- Full Text
- View/download PDF
6. Ophthalmologic and neurologic findings in two children exposed to vigabatrin in utero.
- Author
-
Sorri I, Herrgård E, Viinikainen K, Pääkkönen A, Heinonen S, and Kälviäinen R
- Subjects
- Adult, Child, Epilepsy drug therapy, Female, Functional Laterality, Humans, Male, Neurologic Examination methods, Pregnancy, Reaction Time drug effects, Uterus drug effects, Visual Acuity drug effects, Visual Fields drug effects, Anticonvulsants adverse effects, Prenatal Exposure Delayed Effects, Vigabatrin adverse effects, Vision Disorders etiology
- Abstract
Vigabatrin (VGB) is an important treatment option for infantile spasms. Vigabatrin-induced visual field defects are at present the most important safety issue in the use of the drug. The knowledge concerning VGB-associated visual dysfunction in pediatric patients, particularly in those who have been exposed to VGB in utero is limited. We explored ophthalmic and neurologic findings in two children who have been exposed prenatally to VGB.
- Published
- 2005
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.